최신 ACRP-CP 무료덤프 - ACRP Certified Professional
Which one of the following is a primary objective of a Phase III study of a new IP?
정답: D
설명: (DumpTOP 회원만 볼 수 있음)
After enrolling and treating a few subjects on an investigator-initiated trial, the PI would like to include a subject diary for each trial subject to capture their activities and experiences on the trial regimen. After the PI has generated a diary, what should the PI do next?
정답: C
설명: (DumpTOP 회원만 볼 수 있음)
A clinical trial is conducted to measure the effectiveness of music therapy to reduce anxiety in intensive care unit patients. Patients are randomly assigned to receive headphones with music of their choice or headphones with white noise. The group receiving the white noise headphones is considered which type of control group?
정답: A
설명: (DumpTOP 회원만 볼 수 있음)
A Phase I drug trial has been completed and preparations are being made to proceed to a Phase II trial. Who is responsible for revising the IB with this updated information?
정답: D
설명: (DumpTOP 회원만 볼 수 있음)
Access to study documentation for auditors and inspectors during an audit or inspection at a clinical trial site is the responsibility of the:
정답: A
설명: (DumpTOP 회원만 볼 수 있음)
Who should vote during the IRB/IEC review and discussion process?
정답: A
설명: (DumpTOP 회원만 볼 수 있음)
A protocol requires participants to take IP for 6 months. The protocol allows for any participants who are noncompliant to be replaced by enrolling additional participants, except if it is due to an AE. The investigator has enrolled 12 participants.
The status of the enrolled participants is as follows:
* 3 participants were withdrawn due to noncompliance
* 1 participant withdrew consent after experiencing severe nausea
* 1 participant had to discontinue IP for an unscheduled hospitalization
* 1 participant who is not returning for visits
* 2 participants completed the 6 months of treatment
* 4 participants currently on IP
How many participants should be replaced?
The status of the enrolled participants is as follows:
* 3 participants were withdrawn due to noncompliance
* 1 participant withdrew consent after experiencing severe nausea
* 1 participant had to discontinue IP for an unscheduled hospitalization
* 1 participant who is not returning for visits
* 2 participants completed the 6 months of treatment
* 4 participants currently on IP
How many participants should be replaced?
정답: D
설명: (DumpTOP 회원만 볼 수 있음)
An interim analysis is conducted during a clinical trial. To review the results, the sponsor assigns:
정답: D
설명: (DumpTOP 회원만 볼 수 있음)
A study subject inadvertently disposed of IP medication bottles. The site should report this to the:
정답: D
설명: (DumpTOP 회원만 볼 수 있음)
During a multi-center, double-blind, placebo-controlled Phase III clinical trial evaluating a novel oncology drug, the following situation occurs:
An interim analysis performed by the DSMB reveals that the investigational product (IP) shows a statistically significant improvement in progression-free survival (PFS) compared to the placebo. However, a sub-group analysis indicates a higher incidence of Grade 4 hepatotoxicity in patients with pre-existing mild liver dysfunction.
The sponsor, upon reviewing the DSMB report, decides to unblind the affected sub-group to assess safety.
The trial protocol specifies that unblinding should only occur if a life-threatening situation is identified.
What is the most appropriate next step the sponsor should take?
An interim analysis performed by the DSMB reveals that the investigational product (IP) shows a statistically significant improvement in progression-free survival (PFS) compared to the placebo. However, a sub-group analysis indicates a higher incidence of Grade 4 hepatotoxicity in patients with pre-existing mild liver dysfunction.
The sponsor, upon reviewing the DSMB report, decides to unblind the affected sub-group to assess safety.
The trial protocol specifies that unblinding should only occur if a life-threatening situation is identified.
What is the most appropriate next step the sponsor should take?
정답: D
설명: (DumpTOP 회원만 볼 수 있음)